Skip to main content

European Superstar Stocks: The Rise of GRANOLAS

In both the United States and Europe, a select few large-cap companies dominate the market landscape, driving significant portions of market movements.

While the phenomenon is more pronounced across the Atlantic, European equities also exhibit a concentration of influence among a handful of powerful entities.

europe stock investment portfolio

Akin to the United States' reliance on tech giants for market momentum, Europe showcases its own cadre of influential stocks. Although Europe may not boast trillion-dollar mega-cap companies akin to the GAFA (GOOG, AAPL, META, AMZN), it does harbor a cluster of substantial enterprises increasingly capturing the attention of global investors.

Driving European Market Outperformance

These European juggernauts, aptly termed GRANOLAS, represent some of the continent's largest companies, each with a market capitalization exceeding 200 billion euros. Originally identified by investment bank Goldman Sachs in 2020, the GRANOLAS acronym encompasses a diverse array of sectors, including pharmaceuticals, luxury goods, and technology. 

The roster includes:
  1. GlaxoSmithKline (GSK)
  2. Roche Holding
  3. ASML (ASML)
  4. Nestlé (MYX), 
  5. Novartis (NVS)
  6. Novo Nordisk (NOV)
  7. L'Oréal
  8. LVMH Moet Hennessy Louis Vuitton
  9. AstraZeneca (AZN)
  10. SAP (SAP)
  11. Sanofi (SNY).
Over the years, the composition of this elite group has evolved, with newcomers such as Hermès and Shell joining the ranks while others like GlaxoSmithKline, Sanofi, and SAP have receded. However, certain characteristics remain consistent among these corporate behemoths: robust balance sheets, resilient earnings growth irrespective of economic cycles, and attractive dividend yields.

Contrary to the tech-centric dominance observed in the U.S., Europe's GRANOLAS hail predominantly from the luxury, healthcare, and consumer sectors. Notably, LVMH Moet Hennessy Louis Vuitton SE achieved a historic milestone by surpassing a market capitalization of 400 billion euros, with other members such as Novo Nordisk A/S and ASML NV not far behind.

The stellar performance of these European powerhouses has significantly contributed to the outperformance of indices like the Stoxx 600, surpassing benchmarks like the S&P 500 and Nasdaq 100. Despite their size, GRANOLAS continue to exhibit robust sales growth, driven by their global footprint and dominant market positions.

Moreover, their monopolistic or oligopolistic standing allows them to navigate cost pressures by leveraging pricing power, a particularly desirable trait amid inflationary environments. With solid operating margins and resilient revenue streams, GRANOLAS present an attractive investment proposition, underscored by their ability to generate stable dividends amidst a volatile market backdrop.

A Shift in Global Investment Focus

While the spotlight often shines on tech giants like Nvidia (NVDA), Tesla (TSLA), and the Magnificent 7 in the U.S., discerning investors are increasingly turning their gaze towards Europe's GRANOLAS. Backed by their impressive performance, these European super-stocks offer a compelling alternative for those seeking stability, growth, and dividend income in their portfolios.

The continued ascent of GRANOLAS underscores a broader trend within European equities, where a select group of companies wield disproportionate influence over market movements. As global investors recalibrate their strategies in response to shifting market dynamics, the allure of Europe's premier stocks shines ever brighter. Whether one's investment horizon spans continents or remains firmly rooted in European markets, the emergence of GRANOLAS heralds a new era of investment prominence in the old continent.

Interested in making informed trading and investing decisions?

• Explore our Stock Investor service for insightful investing strategies. 
• If you are looking for dynamic trading experiences, check out Basic+ | Swing AlertOption Income Alert, or our Trading Room. Sign up today for as little as $1 in the first month

Trading Risk Disclaimer

All the information shared is provided for educational purposes only. Any trades placed upon reliance of SharperTrades, LLC are taken at your own risk for your own account. Past performance is no guarantee. While there is great potential for reward trading stocks, cryptos, commodities, options, forex and other trading securities, there is also substantial risk of loss. All trading operations involve high risks of losing your entire investment. You must therefore decide your own suitability to trade. Trading results can never be guaranteed. SharperTrades, LLC is not registered as an investment adviser with any federal or state regulatory agency. This is not an offer to buy or sell stocks, cryptos, forex, futures, options, commodity interests or any other trading securities. Always consult your financial advisor and/or tax pro before making substantial portfolio adjustments. 

Popular posts from this blog

Cathie Wood Dives Into Bargain Tech Stocks Amid Market Volatility

4 Ways Chipotle and Cava Mirror Success in the Fast-Casual Dining Industry